Concierge Style Customer Care Our commitment to concierge style customer care sets us apart
Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Summary: In individuals with both overweight/obesity and type 2 diabetes, the STEP 2 trial reported a mean weight loss of -9.6% with semaglutide 2.4 mg and a mean HbA1c reduction of 1.6%
By targeting and suppressing these inflammatory markers, Semaglutide can lower inflammation throughout the body, offering relief to those dealing with chronic inflammatory conditions like arthritis and other autoimmune diseases
Injection site reactions Mild swelling, redness, or irritation
If more than five days have passed, skip the dose entirely and resume your regular schedule on your next planned injection day